论文部分内容阅读
目的：针对红花注射液颈动脉加压滴注治疗对老年 ACI 患者 MDA 水平与神经功能缺损的改善作用进行分析。方法：随机选择2013年12月～2015年1月期间，我院收治的老年 ACI 患者120例，作为本次研究的对象，将其平均分为对照组和观察组。对照组实施常规治疗，观察组实施红花注射液颈动脉加压滴注治疗。针对两组患者的临床治疗效果、神经功能缺损变化、 MDA 水平等指标进行观察比较。结果：在本次研究中，观察组患者的治疗有效率为96.67％，对照组的治疗有效率为71.67％， P ＜0.05，具有统计学意义。观察组与对照组患者治疗后的神经功能缺损评分与治疗前比较， P ＜0.05，具有统计学意义。且观察组患者治疗后的神经功能缺损评分优于对照组， P ＜0.05，具有统计学意义。治疗后观察组与对照组患者的 MDA 水平与治疗前比较，有显著降低， P ＜0.05，具有统计学意义。治疗后观察组的 MDA 水平下降程度优于对照组， P ＜0.05，具有统计学意义。结论：在急性脑梗死的治疗中，实施红花注射液颈动脉加压滴注治疗，可以提高治疗效果，并对老年患者的 MDA 水平与神经功能缺损，有显著的改善作用。“,”OBJECTIVE: To analyze Safflower injection carotid artery pressure drip treatment on MDA level and the effect of nerve function defect in patients with ACI.METHODS: From December 2013 to January 2015 in our hospital 120 cases of patients with ACI were randomly selected.There were divided into control group (n =60) and observation group (n =60).Control group re-ceived routine therapy and observation group implemented safflower injection carotid artery pressure drip treatment.Clinical therapeutic effects, changes in nerve function defect, MDA level of two groups were observed and compared.RESULTS: In the observation group the treatment effective rate was 96.67% and in the control group the effective rate was 71.67% (P <0.05).There was statisti-cally significant difference.Nerve function defect scale was compared before treatment and after treatment in the two groups (P <0.05).There was statistically significant difference.In observation group after treatment nerve function defect score was better than that in control group (P <0.05).There was statistically significant difference.After treatment the MDA level of the two group de-creased more significantly than that lefore treatment (P <0.05).There was statistically significant difference.After treatment MDA level in the observation group was better than that in the control group (P <0.05).There was statistically significant difference. CONCLUSION: In the treatment of acute cerebral infarction, the implementation of safflower injection carotid artery pressure drip can improve the effect of treatment and MDA level of patients with neurologic deficits has a significant improvement.